Midwifing the vaccine: The When is visible but there ’s much left to do on the Who and How

The big ‘but’ butts into scalability. The usual sticking point of lab-to-arm is hugely multiplied when dealing with a totally new vaccine against a novel virus to be administered in the midst of a raging pandemic.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news